Royalty Pharma plc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Royalty Pharma plc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Royalty Pharma plc - Ordinary Shares - Class A
Rating: 2.646472375
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

35.08 -0.17 (-0.48%)

45.86% Gain from 52W Low

851.9K

XNAS Volume

XNAS 30 Sep, 2025 12:04 PM (EDT)

High Financial Strength

55.6 / 100

Affordable Valuation

52.7 / 100

Technically Neutral

47.9 / 100

Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM

1Yr Price target upside is 28%

7 analysts

Royalty Pharma plc Ordinary Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Royalty Pharma plc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products...

45.86% Gain from 52W Low

SWOT Analysis

Royalty Pharma plc Ordinary Live Price Chart